Volume 5, Issue 15 (Winter 2012)
IJT 2012, 5(15): 558-564 |
Back to browse issues page
1- School of Pharmacy and Pharmaceutical Sciences, Isfahan, Iran. , sadeghi@pharm.mui.ac.ir
2- Isfahan University of Medical Sciences, Isfahan, Iran.
3- Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Isfahan University of Medical Sciences, Isfahan, Iran.
3- Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract: (16113 Views)
Background: Flavonoids have a variety of biological activities, such as anti-allergic, anti-inflammatory, anti-oxidative, free radical scavenging, and anti-mutagenic.
Methods: The cytotoxic effects of three synthesized flavonoid derivatives (K3, K4 and K5) were evaluated against Hela , MDA-MB -231 and HT-29 cancer cells using MTT assay.
Results: The results showed that these flavonoids were not cytotoxic at any tested concentrations (0.1, 0.05, 0.01, and 0.001 mM). To evaluate the possible synergistic effect of synthetic flavonoids with chemotherapeutic agent, the compound (K4) was examined against Hela and MDA-MB-231 cells in combination with different concentrations of doxorubicin (0.01 and 0.001mM). This combination treatment significantly increased the cytotoxicity of doxorubicin (P < 0.05).
Conclusion: Synthesized flavonoids could be used either in combination therapy with other chemotherapeutic agents or used as antioxidants in food supplements.
Methods: The cytotoxic effects of three synthesized flavonoid derivatives (K3, K4 and K5) were evaluated against Hela , MDA-MB -231 and HT-29 cancer cells using MTT assay.
Results: The results showed that these flavonoids were not cytotoxic at any tested concentrations (0.1, 0.05, 0.01, and 0.001 mM). To evaluate the possible synergistic effect of synthetic flavonoids with chemotherapeutic agent, the compound (K4) was examined against Hela and MDA-MB-231 cells in combination with different concentrations of doxorubicin (0.01 and 0.001mM). This combination treatment significantly increased the cytotoxicity of doxorubicin (P < 0.05).
Conclusion: Synthesized flavonoids could be used either in combination therapy with other chemotherapeutic agents or used as antioxidants in food supplements.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |